Profusa Inc. Ordinary Shares PFSA 深 沪
等待开盘 10-10 09:30:00 美东时间
0.3399
-0.037
-9.91%
华盛通- 最 高0.39
- 今 开0.39
- 成交量 144.66万股
- 最 低 0.3351
- 昨 收 0.3773
- 总市值 1226.66万
- 52周最高 2.40
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.265
- 委 比 0.00%
- 总股本 3608.89万
- 历史最高 2.40
- 量 比 0.73
- 振 幅 14.55%
- 历史最低 0.265
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Profusa invests additional $1 million in digital treasury assets
Profusa (NASDAQ:PFSA) announced on Tuesday its second $1 million investment in digital treasury assets to hedge against macroeconomic uncertainties, in line with the company’s treasury management stra...
10-07 20:40
Profusa Invests Additional $1M In Bitcoin As Part Of Digital Treasury Strategy
Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering a next-generation technology platform enabling the continuous monitoring of an individual's biochemistry,
10-07 20:16
OceanFirst Financial Corp. Schedules Earnings Conference Call
OceanFirst Financial Corp. announced it will release its Q3 2025 earnings on October 22, 2025, after market close. A conference call to discuss results will follow on October 23 at 8:00 a.m. ET. Participants can dial 1-833-470-1428 (access code 969824) or listen via the company's website at www.oceanfirst.com. A replay will be available until October 31. OceanFirst Bank N.A., a $13.3 billion regional bank founded in 1902, provides financial servi...
10-02 20:00
Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base
Profusa announced a collaboration with Dr. Yann Gouëffic, a leading vascular surgeon in France, to adopt its Lumee oxygen monitoring technology. Gouëffic and his affiliates treat approximately 8% of all CLTI cases in France. The technology aims to improve patient care by enabling real-time oxygen monitoring at home, addressing a significant clinical need. Profusa’s Lumee system is expanding its presence in Europe, targeting a large endovascular m...
10-01 12:30
Profusa Faces Nasdaq Listing Compliance Challenges
Profusa ( ($PFSA) ) has shared an update. On September 11, 2025, Profusa, Inc. ...
09-17 05:50
Profusa shares are trading higher after the company announced the adoption of NVIDIA technology to power an AI-driven insight portal for continuous biochemistry monitoring.
Profusa shares are trading higher after the company announced the adoption of N...
09-11 20:34
Profusa Approves $100 Million Equity Line of Credit
Profusa ( ($PFSA) ) just unveiled an update. On August 29, 2025, Profusa Inc. h...
09-05 05:49
Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base
Profusa, a digital health company, collaborates with Dr. Koen Deloose, a leading vascular surgeon in Belgium, to advance CLTI treatment using its Lumee Oxygen monitoring system. The partnership aims to improve patient outcomes through innovative technologies and personalized care.
09-04 12:30
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Profusa, Inc., a digital health company specializing in continuous biochemical monitoring, announced that CEO Ben Hwang will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8–10, 2025, at the Lotte New York Palace Hotel. Dr. Hwang’s presentation will be available on demand starting September 5, 2025, at 7:00am ET for registered investors. The company, based in Berkeley, Calif., develops tissue-integrated senso...
09-02 20:05
Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria
Profusa, Inc. has announced a collaboration with Prof. Dr. Marianne Brodmann at the Medical University of Graz, Austria. Prof. Brodmann will adopt and integrate Profusa's Lumee Oxygen platform technology into her practice, involving approximately 1,500 annual vascular procedures. The collaboration aims to enhance patient monitoring and clinical outcomes while expanding the platform's market reach.
08-27 12:45
